Abstract
Migration of both uninfected and infected monocytes into the brain during acute HIV infection likely initiates metabolic changes that can be observed with magnetic resonance spectroscopy (MRS). Herein, we measured changes in brain metabolism during the first year of HIV infection and examined the relationship of these metabolite levels to CD16+ monocyte populations measured in the blood. MRS was performed on nine HIV+ subjects identified during acute HIV infection and nine seronegative control subjects. HIV+ subjects were examined within 90 days of an indeterminate Western blot, then again 2 and 6 months later, during early infection. Blood samples were collected for plasma viral RNA and monocyte subset quantification. HIV+ subjects were identified with acute viral ailment and did not display severe cognitive deficits such as dementia or minor cognitive motor disorder. Changes in lipid membrane metabolism (choline levels) in the frontal cortex and white matter were observed during the initial year of HIV infection. Greater numbers of CD16+ monocytes were associated with lower N-acetylaspartate levels and higher choline levels in the brain. These results suggest that HIV infection induces metabolic changes in the brain early during infection and that these changes may be related to monocyte dynamics in the periphery.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ances BM, Sisti D et al (2009) Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain. Neurology 73:702–708
Chakrabarti L, Hurtrel M et al (1991) Early viral replication in the brain of SIV-infected rhesus monkeys. Am J Pathol 139:1273–1280
Chang L, Ernst T et al (1999a) Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Neurology 52:100–108
Chang L, Ernst T et al (1999b) Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology 53:782–789
Chang L, Lee PL et al (2004) A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age. Neuroimage 23:1336–1347
Clay CC, Rodrigues DS et al (2007) Neuroinvastion of fluorescein-positive monocytes in acute simian immunodeficiency virus infection. J Virol 81:12040–12048
Ellery PJ, Tippett E et al (2007) The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J Immunol 178:6581–6589
Finzi D, Blankson J et al (1999) Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med 5:512–517
Gray F, Scaravillio F et al (1996) Neuropathology of early HIV-1 infection. Brain Pathol 6:1–15
Greco JB, Westmoreland SV et al (2004) In vivo 1 H MRS of brain injury and repair during acute SIV infection in the macaque model of neuroAIDS. Magn Reson Med 51:1108–1114
Groeschel S, Brockmann K et al (2006) Magnetic resonance imaging and proton magnetic resonance spectroscopy of megalencephaly and dilated Virchow-Robin spaces. Pediatr Neurol 34:35–40
Gruber S, Pinker K et al (2008) Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy. Eur J Radiol 68:320–327
Kassutto S, Maghsoudi K et al (2006) Longitudinal analysis of clinical markers following antiretroviral therapy initiated during acute or early HIV type 1 infection. Clin Infect Dis 42:1024–1031
Kaufmann DE, Walker BD (2007) Treatment interruption to boost specific HIV immunity in acute infection. Curr Opin HIV AIDS 2:21–25
Kaul M, Lipton SA (2006) Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS. J Neuroimmune Pharmacol 1:138–151
Kim JP, Lentz MR et al (2005) Relationships between astrogliosis and 1H MR spectroscopic measures of brain choline/creatine and myo-inositol/creatine in a primate model. AJNR Am J Neuroradiol 26:752–759
Kim WK, Sun Y et al (2009) Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage. J Leukoc Biol 87:557–567
Kreis R, Ross BD et al (1992) Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 182:19–27
Lentz MR, Kim WK et al (2009) Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection. Neurology 72:1465–1472
Mellors JW, Kingsley LA et al (1995) Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 122:573–579
Meyerhoff DJ, Bloomer C et al (1999) Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV + patients. Neurology 52:995–1003
Mogensen TH, Marinovskij E et al (2007) Acute demyelinizating encephalomyelitis (ADEM) as initial presentation of primary HIV infection. Scand J Infect Dis 39:630–634
Mohamad MSN, Sacktor NC, et al. (2007) 3 Tesla MR Spectroscopy Reveals Decreased Glutamate and Glutamine levels in frontal white matter in HIV-associated dementia. In: ISMRM 15: Berlin
Moore D, Letendre S, et al. (2010) HIV-associated Neurocognitive Disorder in Acute and Early HIV Infection. In: 17th Conference on Retroviruses and Opportunistic Infections: San Francisco, CA
Perelson AS, Essunger P et al (1997) Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387:188–191
Power C, Selnes OA et al (1995) HIV dementia scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol 8:273–278
Ratai EM, Pilkenton SJ et al (2009) In vivo proton magnetic resonance spectroscopy reveals region specific metabolic responses to SIV infection in the macaque brain. BMC Neurosci 10:63
Rosenberg ES, Altfeld M et al (2000) Immune control of HIV-1 after early treatment of acute infection. Nature 407:523–526
Ross BD, Jacobson S et al (1994) Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology 193:457–463
Schacker TW, Hughes JP et al (1998) Biological and virologic characteristics of primary HIV infection. Ann Intern Med 128:613–620
Schnell G, Price RW et al (2010) Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection. J Virol 84:2395–2407
Williams K, Westmoreland S et al (2005) Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS. J Clin Invest 115:2534–2545
Yoshizawa T, Motonishi S et al (2007) Case of acute primary HIV infection with menigoencephalitis demonstrating high signal intensity of the bilateral globus pallidus in T2-weighted MRI. Rinsho Shinkeigaku 47:597–600
Acknowledgments
This work was supported by NIH grants K25 NS051129 (MRL), R01 NS040237 (KW), R01 NS037654 (KW), U19MH81835 (KW), NS050041 (RGG), AI040873 (ESR), and the National Center for Research Resources (P41 RR14075).
Disclosure
The authors report no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lentz, M.R., Kim, WK., Kim, H. et al. Alterations in brain metabolism during the first year of HIV infection. J. Neurovirol. 17, 220–229 (2011). https://doi.org/10.1007/s13365-011-0030-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13365-011-0030-9